Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Data sources

SEC FORM 432m ago

HOUSE PTR32m ago

SEC 13F32m ago

ROBINHOOD CHAIN32m ago

Public company

Atea Pharmaceuticals, Inc.

AVIRCIK 0001593899

EDGAR filings Open in network

Price$4.31

1 year+33.0%

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections with evidence2

AVIR · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
← Lobbied forevidence
JEFFREY J. KIMBELL & ASSOCIATES, INC.LDA Q1 2026 first quarter · Health issues · Aug 26, 2026

Lobbying

$20K reported · de-duplicated

2026 Q2 $10K via firms2026 Q1 $10K via firms

JEFFREY J. KIMBELL & ASSOCIATES, INC.$10K2026 Q2 · posted Aug 26, 2026 · Health issues
JEFFREY J. KIMBELL & ASSOCIATES, INC.$10K2026 Q1 · posted Aug 26, 2026 · Health issues

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.